CIK: 0001232621 · Show all filings
Period: Q2 2018 (← Previous) (Next →)
Filing Date: Aug 14, 2018
Total Value ($000): $788,960 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | 8,647,398 | $335,952 | 42.6% | $14.10 | +125.8% | COM | 427746102 |
| — | ODONATE THERAPEUTICS INC | 12,412,338 | $274,064 | 34.7% | $24.94 | — | COM | 676079106 |
| — | LA JOLLA PHARMACEUTICAL CO | 4,138,893 | $120,732 | 15.3% | $18.53 | — | COM | 503459604 |
| RCKT | ROCKET PHARMACEUTICALS INC | 2,965,485 | $58,212 | 7.4% | $16.31 | +16.0% | COM | 77313F106 |